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Introduction
Percutaneous closure devices were developed to min-
imise haemorrhagic complications after percutaneous
femoral arterial puncture in diagnostic and interven-
tional radiology. The use of these devices in day case
arteriography in the U.K. is increasing, although most
experience has been in North America, from where
there have been several reports of complications.1±3
Although these devices have been shown to decrease
the time to haemostasis and ambulation in patients
undergoing femoral catheterisation,4 there is a
reported 0.25% incidence of infective arteritis asso-
ciated with their use in native arterial puncture.5
We report a potentially life-threatening complication
following the use of one of these devices after punc-
ture of a synthetic graft.
Report
A 65-year-old male presented with symptoms of right
calf claudication. Two years earlier, he had undergone
aorto-biprofunda bypass grafting with simultaneous
bilateral femoro-popliteal bypass grafts for bilateral
ischaemic rest pain.
Duplex arteriography demonstrated that all three
grafts were still functioning well, but showed a critical
(95%) stenosis in the right tibioperoneal trunk. The
decision to intervene was made to protect the graft
outflow, maintain patency and for symptom relief.
Angioplasty to the right tibioperoneal stenosis was
performed through a percutaneous puncture of the
left aorto-biprofunda graft. Direct puncture of the
Dacron graft was selected because the alternative
approaches, transradial or transbrachial, were consid-
ered too remote for the length of catheters available.
The puncture was closed with a suture mediated
percutaneous closure device (Perclose Inc, Redwood,
CA, U.S.A.) with no immediate complications. Pro-
phylactic antibiotics were not given.
Six weeks later, the patient presented with a painful
discharging sinus at the puncture site. He remained
apyrexial, and blood tests revealed a normal leuko-
cyte count, erythrocyte sedimentation rate, and
C-reactive protein. Serial swabs of the purulent
discharge were taken for culture, but there was no
significant growth. A white cell scan highlighted the
area of the sinus but showed no evidence of more
extensive graft infection. An empirical trial of antibio-
tics produced no improvement and surgical explora-
tion was undertaken.
At operation, the limb of the aorto-biprofunda graft
was exposed proximally from under the inguinal liga-
ment to the anastomoses with the popliteal graft and
profunda femoris artery. The graft was found to be
well incorporated into surrounding tissues by fibrosis,
with the only signs of graft infection confined to the
base of the sinus (Fig. 1). Based on this observation,
a limited distal section of the graft was excised. The
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(600 mg). A rifampicin-soaked, collagen impregnated
interposition Dacron graft (8 mm Fluoropassiv, Sulzer
Vascutek) restored flow from the aorto-biprofunda
graft to the distal graft, with a Carrel patch to the
profunda femoris artery. Microscopy of the excised
graft and sinus tissue failed to identify any organism,
and further culture still produced no significant
growth. Prophylactic broad-spectrum antibiotics
were given postoperatively and the wounds healed
uneventfully. The patient remains symptom-free 6
months later with no sign of recurrent infection.
Discussion
Punctures of synthetic graft materials carry a substan-
tially greater risk of haemorrhagic complications than
in native arteries. This is generally attributed to the
lower compliance of prosthetic graft materials than in
native arterial wall, giving poorer elastic recoil and
puncture sealing after catheter removal. A percutan-
eous closure device may be expected to minimise such
haemorrhagic complications.
An infection of the graft may have occurred without
the use of a closure device although this is a rare
occurrence when native arteries are punctured.6
The use of a percutaneous closure device increases
the complexity of the procedure and requires addi-
tional exchanges of catheters through the puncture
site. This might be expected to increase the risk of
bacterial inoculation, especially as most angiography
suites are not designed and maintained to the same
levels of sterility compared to an operating theatre.
The device we used leaves a permanent non-absorb-
able 3/0 braided polyester suture at the arterial
puncture site. There is a higher risk of infection in
general surgery with braided sutures than with mono-
filaments,7 and this may also have been a factor in the
development of infection. It is not uncommon for
routine bacterial cultures of a graft to fail to identify
a causative organism especially after antibiotic ther-
apy. Some authors have reported that sonic disruption
of infected graft tissue significantly increases the rate
of identification of Staphylococcus epidermidis graft
infections.8
This case report highlights the risk of infection asso-
ciated with the use of non-absorbable suture mediated
percutaneous closure devices. A spreading graft
infection could have been disastrous and required
extensive excision of all the synthetic material.
Such potentially life-threatening implications of graft
infection should be carefully weighed up before using
a suture mediated percutaneous closure device in syn-
thetic graft puncture. Although antibiotic prophylaxis
reduces wound infections in vascular surgery, they
have not been proven to decrease the incidence of
graft infection.9 Despite this, the authors would
recommend antibiotic prophylaxis and avoiding the
use of percutaneous closure devices when puncturing
synthetic grafts.
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Fig. 1 The excised section of the limb of the aorto-biprofunda graft.
The proximal and distal margins of the graft are well-incorporated
into the surrounding fibrotic tissue. However, there are characteris-
tic signs of graft infection at the base of the sinus, with loosening of
the graft material and exposure of the Dacron. The braided suture
of the percutaneous closure device can clearly be seen in the centre
of this area.
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